Rapidai Inc. landed $75 million in a series C financing led by Vista Credit Partners. The funds will be used to fuel development of additional indications and expand market reach of its artificial intelligence (AI)-powered clinical decisionmaking and workflow support technology. With this latest round, the San Mateo, Calif.-based company has raised approximately $100 million, according to Crunchbase. Read More
Cardiologists have debated for some time whether obstructive sleep apnea (OSA) is a proven factor in a patient’s risk for heart disease, but the U.S. National Institutes of Health says newly published studies identify the specific mechanisms for this association. The studies offered data from more than 4,500 subjects and affirms the notion that OSA-driven hypoxia correlates well with the occurrence of a primary cardiovascular event, but the NIH says these findings need to be confirmed in another trial, hopefully one with enrollees whose OSA is deemed a high-risk version of the condition. Read More
In good news for those who toss and turn in the night with restless legs syndrome and their bed partners, bioelectronic technology appears to reduce the disruptive and uncontrolled movement. Researchers claimed that the NTX100 tonic motor activation (TOMAC) therapy, developed by Noctrix Health Inc., has the potential to transform treatment for people with restless legs syndrome (RLS) who are resistant to medications. Read More
The U.S. Security and Exchange Commission’s final rule for disclosure of cybersecurity incidents would seem to weigh more heavily on device makers and their client hospitals than on other industries, particularly given that the draft rule required a four-day notification of any such events. The final rule retains that requirement to notify investors of any such breach within four days, although the SEC relented on the content of such disclosures to ease concerns about the potential for disclosures to amplify the cybersecurity threat. Read More
Baird Medical Investment Holdings Ltd.’s disposable microwave ablation (MWA) needle was approved by China’s National Medical Products Administration for treatment of benign thyroid nodules, which will help the company build a portfolio of products for thyroid diseases. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anteris Technologies, Augmedics, Electrocore, Fuzionaire, Holo Surgical, Juno, Pixium, Surgalign, T2, Tivic, Xtant. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Axial 3D, Imeka, Magnetiq-eye. Read More
